Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers.
Wang Y, Zou J, Li Y, Jiao X, Wang Y, Zhuo N, Gao M, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Shen L, Zhang H, Lu Z.
Wang Y, et al. Among authors: li y, li j.
Front Immunol. 2022 Sep 8;13:987568. doi: 10.3389/fimmu.2022.987568. eCollection 2022.
Front Immunol. 2022.
PMID: 36159840
Free PMC article.